Noemi Busquets1, Carmen Gómez Vaquero2, Jesús Rodríguez Moreno2, Daniel Roig Vilaseca3, Javier Narváez2, Loreto Carmona4, Joan M Nolla5. 1. Servicio de Reumatología, Hospital General de Granollers, Granollers, Barcelona, Spain. 2. Servicio de Reumatología, IDIBELL-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. 3. Servicio de Reumatología, Hospital Moisés Broggi, Sant Joan Despí, Barcelona, Spain. 4. Facultad de Ciencias de la Salud, Universidad Camilo José Cela, Madrid, Spain; Instituto de Salud Musculoesquelética, Madrid, Spain. 5. Servicio de Reumatología, IDIBELL-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: jm.nolla@bellvitgehospital.cat.
Abstract
OBJECTIVE: To assess the bone mineral density (BMD) and the frequency of osteoporosis and clinical fractures in a large group of Spanish patients with psoriatic arthritis (PsA). PATIENTS AND METHODS: BMD was determined by DXA in all the patients who were willing to participate and had peripheral PsA regularly evaluated in a tertiary university hospital. All patients underwent a physical examination and general laboratory analysis. We gathered demographic and clinical variables related with BMD and risk of fractures. We also recorded the history of clinical low impact fractures. The population of reference to calculate T-score and Z-score came from a Spanish database. RESULTS: One hundred and fifty-five patients were included (64 postmenopausal women, 26 premenopausal women and 65 men). The clinical forms of PsA were: 46% oligoarticular and 54% polyarticular. Mean disease duration was 13.7±9.4 years and mean ESR was 21.8±13.9mm/h; 66% of patients had received glucocorticoid treatment. We found no differences in BMD status between the patients and the Spanish general population, neither in the whole series nor in each defined subgroup. Frequency of osteoporosis was 16%; it was higher in postmenopausal women (28%) than in men (9%) or premenopausal women (4%). Frequency of clinical fractures was 13%; it accounted specially in postmenopausal women. CONCLUSIONS: The magnitude of the problem of osteoporosis in PsA seems to be mild.
OBJECTIVE: To assess the bone mineral density (BMD) and the frequency of osteoporosis and clinical fractures in a large group of Spanish patients with psoriatic arthritis (PsA). PATIENTS AND METHODS: BMD was determined by DXA in all the patients who were willing to participate and had peripheral PsA regularly evaluated in a tertiary university hospital. All patients underwent a physical examination and general laboratory analysis. We gathered demographic and clinical variables related with BMD and risk of fractures. We also recorded the history of clinical low impact fractures. The population of reference to calculate T-score and Z-score came from a Spanish database. RESULTS: One hundred and fifty-five patients were included (64 postmenopausal women, 26 premenopausal women and 65 men). The clinical forms of PsA were: 46% oligoarticular and 54% polyarticular. Mean disease duration was 13.7±9.4 years and mean ESR was 21.8±13.9mm/h; 66% of patients had received glucocorticoid treatment. We found no differences in BMD status between the patients and the Spanish general population, neither in the whole series nor in each defined subgroup. Frequency of osteoporosis was 16%; it was higher in postmenopausal women (28%) than in men (9%) or premenopausal women (4%). Frequency of clinical fractures was 13%; it accounted specially in postmenopausal women. CONCLUSIONS: The magnitude of the problem of osteoporosis in PsA seems to be mild.
Keywords:
Artritis psoriásica; Bone densitometry; Bone mineral density; Densidad mineral ósea; Densitometría ósea; Fracturas; Fractures; Osteoporosis; Psoriatic arhritis
Authors: T Y Zhu; J F Griffith; L Qin; V W Y Hung; T-N Fong; S-K Au; A W Kwok; P-C Leung; E K Li; L-S Tam Journal: Osteoporos Int Date: 2014-08-27 Impact factor: 4.507
Authors: Alexis Ogdie; Lauren Harter; Daniel Shin; Joshua Baker; Junko Takeshita; Hyon K Choi; Thorvardur Jon Love; Joel M Gelfand Journal: Ann Rheum Dis Date: 2017-01-16 Impact factor: 19.103